Hasn’t @Davisite previously indicated that most big pharma interest occurs after phase 2 data .
To be honest , although it would be nice for holders , any deals with “BP” are a way off .
Although 110 gives some confidence 220 has to go through all the regulatory processes . BP would , I think, wait and let RAC use its own resources up .
I’m not sure when “negotiating from a position of strength “ can happen
Ann: Updated Strategy and Investor Presentation, page-235
-
- There are more pages in this discussion • 274 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.69 |
Change
0.000(0.00%) |
Mkt cap ! $288.0M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.57 | $387.6K | 237.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 807 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.69 | 2376 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |